MELISSA MCGUIRE: Open Payments
NPI 1881369460 · MARION, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$559 in 42 payments from 13 companies in 2025. Trend: 2023 $445 · 2024 $728 · 2025 $559
Food & beverage: $559
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $248 |
| AstraZeneca Pharmaceuticals LP | 4 | $63 |
| Lilly USA, LLC | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| Novo Nordisk Inc | 1 | $23 |
| Abbott Laboratories | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $18 |
| Alexion Pharmaceuticals, Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $16 |
Products named: VRAYLAR, BEXSERO, UBRELVY, AIRSUPRA, MOUNJARO, VIBERZI, FREESTYLE LIBRE 3, KISUNLA.
Industry payments across OH — which companies pay providers there.
